Drug Interactions and the Cytochrome P450 System
- 1 January 1995
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 29 (Supplement), 45-52
- https://doi.org/10.2165/00003088-199500291-00008
Abstract
On the basis of the data currently available, the wild type cytochrome P450 2C19 (CYP2C19)gene appears to be absent in 2 to 6% of Caucasian populations and up to 20% of Asian populations. A poor...Keywords
This publication has 44 references indexed in Scilit:
- S-Mephenytoin hydroxylation phenotypes in a Jordanian population*Clinical Pharmacology & Therapeutics, 1995
- Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study*Clinical Pharmacology & Therapeutics, 1995
- Debrisoquine and mephenytoin oxidation in Sinhalese: a population study.British Journal of Clinical Pharmacology, 1994
- Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism.British Journal of Clinical Pharmacology, 1994
- Fluvoxamine is a potent inhibitor of cytochrome P4501A2Biochemical Pharmacology, 1993
- Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokineticsClinical Pharmacology & Therapeutics, 1992
- Fluoxetine and norfluoxetine are potent inhibitors of P450IID6‐the source of the sparteine/debrisoquine oxidation polymorphism [letter]British Journal of Clinical Pharmacology, 1991
- The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramineClinical Pharmacology & Therapeutics, 1991
- Frequency of impaired mephenytoin 4′-hydroxylation in an Indian population [letter]British Journal of Clinical Pharmacology, 1990
- Slow Omeprazole Metabolizers Are Also Poor S-Mephenytoin HydroxylatorsTherapeutic Drug Monitoring, 1990